LEPAXIM Trademark

Trademark Overview


On Friday, September 12, 2014, a trademark application was filed for LEPAXIM with the United States Patent and Trademark Office. The USPTO has given the LEPAXIM trademark a serial number of 79156319. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, November 13, 2017. This trademark is owned by Novartis AG. The LEPAXIM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
lepaxim

General Information


Serial Number79156319
Word MarkLEPAXIM
Filing DateFriday, September 12, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, November 13, 2017
Registration Number4718692
Registration DateTuesday, April 14, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 27, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateMonday, November 13, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Friday, June 8, 2018NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, June 8, 2018DEATH OF INTERNATIONAL REGISTRATION
Friday, July 3, 2015NOTIFICATION PROCESSED BY IB
Wednesday, June 17, 2015FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, June 17, 2015FINAL DISPOSITION PROCESSED
Thursday, May 14, 2015GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, April 14, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, January 27, 2015PUBLISHED FOR OPPOSITION
Wednesday, January 7, 2015NOTICE OF PUBLICATION
Monday, December 15, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 13, 2014APPLICATION FILING RECEIPT MAILED
Tuesday, December 9, 2014ASSIGNED TO EXAMINER
Tuesday, December 9, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 8, 2014LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 4, 2014SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB